Behind the reality of H1N1 vaccine
Posted on November 6, 2009
Filed Under H1N1 Prevention | Leave a Comment
This time we have a wash of shame SARS, walk in front of the United States to become the world’s first influenza A H1N1 influenza vaccines can be applied to countries. At the same time, established the principle of vaccination programs to give priority to protect students, medical personnel, military police and other key staff groups, as well as the National Day parade.
With the vaccine is a good thing, but the academician Zhong Nanshan said that if the vaccine in mass immunization should be conducted immediately, expressed reservations. In fact, whether the vaccine volume, national attitude is different. For example, the U.S. Minister of Health, CDC experts have said that he has, and will soon be allowed to produce a new vaccine pharmaceutical companies, just on standby, do not rush to mass production.
Have to admit, the scientific understanding of new types of influenza viruses, but also very limited, there are many unknown areas and uncertainties. Hasty mass production and vaccination, it may lead to counterproductive results. Of course, out of the public, the basic attitude of life is responsible for a high degree of vigilance is imperative in advance for the record, this is also the lessons of SARS to us. Not the case, then it is tantamount to replace the scientific sense and luck. From this perspective, the face of a stream, the Government’s performance is satisfactory. However, in the scientific front, we have still to maintain the truth-seeking and truth-seeking attitude.
To date, influenza A H1N1 influenza virus if the mutation is to become another one, two or more viruses, What is the relationship between them, the virus will become more lethal or even harmful, science has yet to find out. The vaccine out of the laboratory to clinical use, but also to do extensive research and experimentation. Whether the vaccine itself for different age and gender groups should be different, how to minimize side effects? Therefore, the question of whether the vaccination, I think we should respect the citizens right to choose.
From the point of view in case that a large number of vaccine production and stockpiling of emergency that can and necessary. As early as June this year, the Ministry of Health Emergency Response Office has made it clear that the “11″ before the state will reserve the required 1% of the total population of about 13 million vaccines. This is very good news, in addition to the masses happy, the concept of a flow plate rose 6.35%, a flow of vaccine stocks Tiantan Biological Products, Westlands biology, Sea King bio 3 Stock Qi Shuashua sealed daily limit, while 12 A current concept stock , have also shut the daily limit.
In fact, in South Asia, Africa and other poor countries, large-scale epidemics every year is almost a norm has been the lack of public concern. In China, the A flow is concerned, we can not forget the other serious public disease. Great concern the whole society and government-oriented, so a lot of pharmaceutical companies, research organizations are enthusiastic. A stream behind the vaccine, refraction is precisely this reality.
Comments
Leave a Reply